BackEssa Pharma Overview

Essa Pharma Cost of Revenue

Cost of Revenue analysis for EPIX.

Quarterly Cost of Revenue

$16382.00
27.72% YoY

As of Jun 30, 2025

Annual Cost of Revenue (TTM)

$16382.00
82.76% YoY

Trailing 12 months ending Jun 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)